COVID-19 has changed the healthcare landscape
Patients have faced new challenges during the COVID-19 pandemic, with healthcare providers less accessible and fears of exposure to the virus if they leave their homes to get treatment. This survey explores how COVID-19 changed their care experience, how they felt about those changes and what new behaviors they want to continue in the future.
The survey results are from 2,700 patients located in the United States, the United Kingdom, France, Germany, China and Japan with participants that had to have been going to a health care facility for treatment or self-administering at home and have one of the following conditions: Cardiovascular, Immunology and Oncology.
Patients chose to defer and change their care
As restrictions came into effect, patients faced difficult choices about whether and how to continue their treatments. Many healthcare providers cancelled appointments, and transportation options were shut down. Patients were afraid to risk exposure to COVID-19 by going to their healthcare providers for regular treatment, and many deferred or even changed their treatments.
Clinical trials were disrupted by COVID-19. For trials that continued, the use of virtual care was critical for consultations, treatment, and monitoring, but was not as widely adopted in clinical trials as it was for the care that the patient population received from their regular healthcare providers.
Reimagining patient engagement
As patients avoided healthcare facilities, they learned to use new technologies to continue their care. Virtual tools became essential lifelines for communication and guidance for patients now administering their own treatments at home. By using technology to support communication and care, healthcare providers were largely able to maintain or even improve on the patient experience. Patients appreciated the more personalized interactions, the faster response time, and the convenience of being able to manage and monitor their care from home.
How to reimagine patient engagement
The COVID-19 crisis has significantly impacted the patient care paradigm, and the ripple effects have altered patient behaviors and expectations, requiring a significant change in how life sciences companies engage with and support patients.